www.finanzen.net bietet Finanznachrichten zum weltweiten Boersengeschehenhttp://www.finanzen.netde-definanzen.net GmbHhttp://images.finanzen.net/images/finanzen_net_neu.gifhttp://www.finanzen.nethttp://www.finanzen.net/nachricht/aktien/Biogen-hofft-auf-baldige-Vermarktung-von-Fampyra-in-Europa-1135112    ZUG (dpa-AFX) - Gute Nachrichten f&uuml;r den US-Biotechkonzern Biogen (<a href="/aktien/Biogen_Idec-Aktie">Biogen Idec</a>): Die europ&auml;ischen Arzneimittelregulierer haben ihre anfangs negative Einsch&auml;tzung zum Multiple-Sklerose-Mittel Fampyra ...http://www.finanzen.net/nachricht/aktien/Biogen-hofft-auf-baldige-Vermarktung-von-Fampyra-in-Europa-1135112http://www.finanzen.net/nachricht/Acorda-Therapeutics-Announces-Filing-of-Patent-Extension-Applications-for-AMPYRA-dalfampridine-760492 <style type="text/css"> <!-- .bwtextaligncenter {text-align: center} --> </style> <a href="/aktien/Acorda_Therapeutics,-Aktie">Acorda Therapeutics,</a> Inc. (Nasdaq: ACOR) today announced that the Company has submitted applications ...http://www.finanzen.net/nachricht/Acorda-Therapeutics-Announces-Filing-of-Patent-Extension-Applications-for-AMPYRA-dalfampridine-760492http://www.finanzen.net/nachricht/Acorda-Therapeutics-to-Present-at-the-Cowen-and-Company-30th-Annual-Health-Care-Conference-750595 <style type="text/css"> <!-- .bwtextaligncenter {text-align: center} --> </style> <a href="/aktien/Acorda_Therapeutics,-Aktie">Acorda Therapeutics,</a> Inc. (Nasdaq: ACOR) today announced that Ron Cohen, M.D., President CEO, will ...http://www.finanzen.net/nachricht/Acorda-Therapeutics-to-Present-at-the-Cowen-and-Company-30th-Annual-Health-Care-Conference-750595http://www.finanzen.net/nachricht/Acorda-Therapeutics-Announces-Availability-of-AMPYRA-dalfampridine-749798 <style type="text/css"> <!-- .bwlistitemmarginbottom {margin-bottom: 10.0px} .bwtextaligncenter {text-align: center} --> </style> <!-- sh_cad_1 --> <a href="/aktien/Acorda_Therapeutics,-Aktie">Acorda Therapeutics,</a> Inc. (Nasdaq: ACOR) ...http://www.finanzen.net/nachricht/Acorda-Therapeutics-Announces-Availability-of-AMPYRA-dalfampridine-749798http://www.finanzen.net/nachricht/Acorda-Therapeutics-to-Participate-in-Panel-at-the-RBC-Capital-Markets-Healthcare-Conference-748282 <style type="text/css"> <!-- .bwtextaligncenter {text-align: center} --> </style> <a href="/aktien/Acorda_Therapeutics,-Aktie">Acorda Therapeutics,</a> Inc.(Nasdaq: ACOR) today announced that Ron Cohen, M.D., President ...http://www.finanzen.net/nachricht/Acorda-Therapeutics-to-Participate-in-Panel-at-the-RBC-Capital-Markets-Healthcare-Conference-748282http://www.finanzen.net/nachricht/Acorda-Therapeutics-Reports-Fourth-Quarter-and-Full-Year-2009-Financial-Results-746554 <style type="text/css"> <!-- .bwcellpaddingbottom1 {padding-bottom: 2.0px} .bwcellpaddingbottom3 {padding-bottom: 4.0px} .bwcellpaddingleft0 {padding-left: 0.0px} .bwcellpaddingleft4 {padding-left: 20.0px} .bwcellpaddingright0 {padding-right: 0.0px} .bwcellparagraphmargin ...http://www.finanzen.net/nachricht/Acorda-Therapeutics-Reports-Fourth-Quarter-and-Full-Year-2009-Financial-Results-746554http://www.finanzen.net/nachricht/Acorda-Therapeutics-Announces-Adrian-L-Rabinowicz-Joins-as-Senior-Vice-President-of-Medical-Affairs-745837 <style type="text/css"> <!-- .bwtextaligncenter {text-align: center} --> </style> <a href="/aktien/Acorda_Therapeutics,-Aktie">Acorda Therapeutics,</a> Inc. (Nasdaq: ACOR) announced today that Adrian L. Rabinowicz, M.D., FAAN, has ...http://www.finanzen.net/nachricht/Acorda-Therapeutics-Announces-Adrian-L-Rabinowicz-Joins-as-Senior-Vice-President-of-Medical-Affairs-745837http://www.finanzen.net/nachricht/Acorda-Therapeutics-to-Host-Conference-Call-to-Report-Fourth-Quarter-and-Full-Year-2009-Financial-Results-on-February-23-2010-743839 <style type="text/css"> <!-- .bwtextaligncenter {text-align: center} --> </style> <a href="/aktien/Acorda_Therapeutics,-Aktie">Acorda Therapeutics,</a> Inc. (Nasdaq: ACOR) announced today that it will host a conference call and ...http://www.finanzen.net/nachricht/Acorda-Therapeutics-to-Host-Conference-Call-to-Report-Fourth-Quarter-and-Full-Year-2009-Financial-Results-on-February-23-2010-743839http://www.finanzen.net/nachricht/Acorda-Therapeutics-to-Present-at-the-12th-Annual-BIO-CEO-Investor-Conference-736795 <style type="text/css"> <!-- .bwtextaligncenter {text-align: center} --> </style> <a href="/aktien/Acorda_Therapeutics,-Aktie">Acorda Therapeutics,</a> Inc.(Nasdaq: ACOR) today announced that Ron Cohen, M.D., President ...http://www.finanzen.net/nachricht/Acorda-Therapeutics-to-Present-at-the-12th-Annual-BIO-CEO-Investor-Conference-736795http://www.finanzen.net/nachricht/Acorda-Therapeutics-Announces-Pricing-and-Patient-Assistance-Programs-for-AMPYRA-dalfampridine-736753 <style type="text/css"> <!-- .bwlistitemmarginbottom {margin-bottom: 10.0px} .bwtextaligncenter {text-align: center} --> </style> <!-- sh_cad_1 --> <a href="/aktien/Acorda_Therapeutics,-Aktie">Acorda Therapeutics,</a> Inc. (Nasdaq: ACOR) ...http://www.finanzen.net/nachricht/Acorda-Therapeutics-Announces-Pricing-and-Patient-Assistance-Programs-for-AMPYRA-dalfampridine-736753